Neurons Fight Back

Total Page:16

File Type:pdf, Size:1020Kb

Neurons Fight Back RESEARCH HIGHLIGHTS URLsHIGHLIGHT ADVISORS ADRIANO AGUZZI VIRAL INFECTION UNIVERSITY HOSPITAL OF ZÜRICH, ZÜRICH, SWITZERLAND NORMA ANDREWS Neurons fight back YALE UNIVERSITY SCHOOL OF MEDICINE, NEW HAVEN, CT, USA Viral infection induces an innate ARTURO CASADEVALL immune response in neurons, a THE ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY, USA group led by Monique Lafon at the Pasteur Institute in Paris, France, has RITA COLWELL UNIVERSITY OF MARYLAND found. It was previously thought that BIOTECHNOLOGY INSTITUTE, the nervous system relied solely on BALTIMORE, MD, USA glial cells to detect infection. STANLEY FALKOW Lafon and colleagues used in vitro STANFORD UNIVERSITY SCHOOL cultures of a human post mitotic OF MEDICINE, STANFORD, neuron-derived cell line, NT2-N, CA, USA which displays characteristics of TIMOTHY FOSTER fully mature human neurons upon TRINITY COLLEGE, DUBLIN, transplantation into the brain, and IRELAND infected them with rabies virus KEITH GULL (RABV) or herpes simplex type 1 UNIVERSITY OF OXFORD, virus (HSV-1). OXFORD, UK Searching for neuronal genes of NEIL GOW which transcription is upregulated UNIVERSITY OF ABERDEEN, during infection through microarray ABERDEEN, UK analysis (using cut-off of a twofold HANS-DIETER KLENK increase to identify upregulated PHILIPPS UNIVERSITY, MARBURG, GERMANY genes), they found that RABV infec- tion increased the transcription of other hand, did not upregulate IFN-β of Gram-negative bacteria, had BERNARD MOSS 228 genes, and HSV-1 infection gene transcripts. Microarray results limited effect. In addition, human NIAID, NATIONAL INSTITUTES OF HEALTH, BETHESDA, MD, increased the transcription of 263 were confirmed by real-time PCR, postmitotic neurons were responsive USA genes. RABV upregulated 56 genes of immuno cytochemistry and ELISA. to a treatment with IFN-β, suggest- JOHN REX the immunity cluster of genes (24% Microarray analysis also revealed ing that they also express receptors α/β α/β). ASTRAZENECA, CHESHIRE, UK of all genes upregulated by RABV), that NT2-N cells express genes that to IFN- (IFN-R whereas HSV-1 upregulated only 13 code for molecules which can sense These results establish that human DAVID ROOS UNIVERSITY OF PENNSYLVANIA, genes in this cluster (4.9% of all genes double-stranded RNA (dsRNA, neurons are capable of sensing and PHILADELPHIA, PA, USA upregulated by HSV-1). Of all the a molecular signature of RNA responding to viral infection, and PHILIPPE SANSONETTI genes upregulated by RABV, the 25 viruses), including Toll-like recep- that dsRNA could be the main viral INSTITUT PASTEUR, genes for which expression was most tor 3 (TLR3). This was confirmed element that is sensed by human neu- PARIS, FRANCE strongly stimulated were all involved by immunocytochemistry using rons as a trigger of an innate immune CHIHIRO SASAKAWA in the innate immune response, antibody directed against the human response. UNIVERSITY OF TOKYO, including the interferon-β (IFN-β) TLR3. Treatment of NT2-N cells Annie Tremp TOKYO, JAPAN β gene, IFN- primary and secondary with dsRNA led to the upregulation References and links ROBIN WEISS response genes, as well as genes for of some genes that are involved in ORIGINAL RESEARCH PAPER Préhaud, C., UNIVERSITY COLLEGE LONDON, chemokines, inflammatory cytokines innate immunity. Similar treatment Mégret, F., Lafage, M. & Lafon, M. Virus infection LONDON, UK switches TLR-3-positive human neurons to and molecules with antiviral activi- with lipopolysaccharide, found on the become strong producers of beta interferon. ties. Infection with HSV-1, on the outer leaflet of the outer membrane J. Virol. 79, 12893–12904 (2005) NATURE REVIEWS | MICROBIOLOGY VOLUME 3 | DECEMBER 2005 | 907 RESEARCH HIGHLIGHTS BACTERIAL SECRETION that their vast quantities of secreted providing evidence to support their proteins are folded correctly have suggestion that it provides a special- been largely unknown until recently. ized environment in which newly In the streptococci, it was known formed proteins can interact with Specialized ExPort that, although only the general chaperones and accessory proteins. secretory (Sec) pathway is present, Their recent experimental work has Gram-positive microorganisms face secretion is a complex process that focused on HtrA (DegP), an extra- a unique challenge when it comes involves chaperones and accessory cellular serine protease also known to protein folding and secretion. factors. In addition, the existence of to function as a chaperone for several Although all microorganisms lack the a putative secretion microdomain S. pyogenes secreted proteins, includ- endoplasmic reticulum (ER) found in Streptococcus pyogenes was first ing SpeB. Using immunoelectron in eukaryotes, Gram-negatives have revealed by Jason Rosch and Michael microscopy, it was found that the dis- a periplasmic space where nascent Caparon in Science last year. Then, tribution of HtrA on the streptococcal polypeptides can be folded before immunogold electron microscopy surface was similar to the distribution secretion. This space is lacking in showed that SpeB — a cysteine pro- of the ExPortal — clustered at a single Gram-positives, and the mecha- tease, and one of the most abundant discrete location distal from both cell nisms these organisms use to ensure S. pyogenes secreted proteins — was poles. Further work showed that HtrA localized to a discrete location at the co-localizes with SpeB, providing cell hemisphere. Given that they also evidence that the ExPortal provides detected a high concentration of Sec an environment in which chaperones translocons in this area, Rosch and and substrates can interact. Caparon proposed that this location Previous work had shown that was a specialized microdomain for both the proteolytic and chaperone protein export, which they termed functions of HtrA can be involved the ExPortal. in protein folding and maturation. Now, in a paper available online Here, Rosch and Caparon found that in Molecular Microbiology, Rosch and the serine-protease activity of HtrA Immunogold electron micrographs showing the co-localization of HtrA tagged at the C terminus (18-nm beads) and SecA (12-nm beads). Reproduced with permission from Caparon have undertaken a more was crucial for SpeB maturation, Molecular Microbiology © (2005) Blackwell Publishing. detailed analysis of the ExPortal, although they did not show directly ANTIFUNGALS HSP90 might actually potentiate the strongly reduced fluconazole resistance in all appearance of new phenotypes. Hsp90-dependent resistant strains. Leah Cowen and Susan Lindquist These findings reveal an attractive A helping hand examined the role of Hsp90 in the evolution therapeutic strategy against fungal infection, of resistance to antifungal drugs. Using rapid as similar results were seen with several Hsp90 is well known for its role as a selection of three strains of Saccharomyces fungal pathogens. It is particularly significant molecular chaperone — a protein that assists cerevisiae with varying levels of Hsp90, that Hsp90 was crucial for the evolution of the folding of other proteins (‘clients’). Now, they demonstrated that the development antifungal resistance in clinical isolates of research published in Science reveals that of resistance depended on high-level Candida albicans collected from an Hsp90 might also influence the evolution expression of Hsp90. Moreover, Hsp90 was HIV-infected individual. With continued of new traits by potentiating the phenotypic required to maintain resistance rather than exposure to fluconazole, the clinical isolates effect of genetic variation. Studies of the just to cope with the initial selection stress. evolved towards Hsp90-independent evolution of drug resistance in several The Hsp90-dependent effect was specific resistance, prompting speculation that Hsp90 strains of pathogenic fungi demonstrate an to mutants generated by rapid selection, initially allows the phenotype to be expressed essential role for Hsp90 and its client protein which favours mutations that prevent the but that environmental stress drives the cell calcineurin, and implicate Hsp90 as a novel accumulation of toxic metabolites, rather towards stabilizing the resistant phenotype. antifungal target. than gradual selection which involves Inhibiting Hsp90 early in infection could As a chaperone for many signal upregulation of a multidrug transporter. therefore render resistant fungal pathogens transducers, Hsp90 is able to ‘buffer’ the However, in 11 previously identified sensitive to conventional treatment or could effects of genetic variation by enabling the S. cerevisiae drug-resistant deletion strains, all prevent the initial development of antifungal- cell to tolerate mutations. Although Hsp90 were found to be Hsp90-dependent, showing drug resistance. Moreover, Hsp90 inhibitors is highly inducible following environmental that Hsp90 can influence the resistance are already being evaluated in clinical trials stress, the demands of stress-induced protein caused by a variety of different genetic lesions. for cancer, and seem to be well tolerated at misfolding can outpace its induction, But how does Hsp90 achieve this? One levels that achieve significant inhibition. enabling previously silent mutations to possibility is that a common regulator exists Joanna Owens, Associate Editor, act combinatorially and generate new to mediate Hsp90-dependent effects on Nature Reviews Drug Discovery phenotypes. It now seems that Hsp90 has yet different mutations. An obvious candidate another role in the emergence
Recommended publications
  • Infection and Immunity
    INFECTION AND IMMUNITY VOLUME 56 0 JANUARY 1988 0 NUMBER 1 J. W. Shands, Jr., Editor in Chief Dexter H. Howard, Editor (1991) (1989) University of California University ofFlorida, Gainesville Peter F. Bonventre, Editor (1989) Los Angeles, Calif. Phillip J. Baker, Editor (1990) University of Cincinnati Stephen H. Leppla, Editor (1991) National Institute ofAllergy and Cincinnati, Ohio U.S. Army Medical Research Institute Infectious Diseases Roy Curtiss III, Editor (1990) of Infectious Diseases Bethesda, Md. Washington University Frederick, Md. Edwin H. Beachey, Editor (1988) St. Louis, Mo. Stephan E. Mergenhagen, Editor (1989) VA Medical Center National Institute ofDental Research Memphis, Tenn. Bethesda, Md. EDITORIAL BOARD Julia Albright (1989) Stanley Falkow (1988) Jerry R. McGhee (1988) Charles F. Schachtele (1988) Leonard t. Altman (1989) Joseph Ferretti (1989) Floyd C. McIntire (1988) Julius Schachter (1989) Michael A. Apicella (1988) Richard A. Finkelstein (1989) John Mekalanos (1989) Patrick Schlievert (1990) Neil R. Baker (1989) Vincent A. Fischetti (1989) Jiri Mestecky (1989) June R. Scott (1990) Alan Barbour (1989) David FitzGerald (1989) Suzanne M. Michalek (1989) Philip Scott (1988) John B. Bartlett (1988) Robert Fitzgerald (1989) David C. Morrison (1989) Gerald D. Shockman (1989) Joel B. Baseman (1988) James D. Folds (1988) Steven Mosely (1990) W. A. Simpson (1988) Robert E. Baughn (1990) Peter Gemski (1988) Antony J. Mukkada (1990) Phillip D. Smith (1988) Gary K. Best (1988) Robert Genco (1988) Robert S. Munford (1989) Ralph Snyderman (1988) Jenefer Blackwell (1988) Ronald J. Gibbons (1988) Juneann W. Murphy (1990) Maggie So (1989) Arnold S. Bleiweis (1990) Jon Goguen (1989) H. Nikaido (1989) P. Frederick Sparling (1990) William H.
    [Show full text]
  • Antimicrobial Resistance and the Role of Vaccines
    PROGRAM ON THE GLOBAL DEMOGRAPHY OF AGING AT HARVARD UNIVERSITY Working Paper Series Antimicrobial Resistance and the Role of Vaccines David E. Bloom, Steven Black, David Salisbury, and Rino Rappuoli June 2019 PGDA Working Paper No. 170 http://www.hsph.harvard.edu/pgda/working/ Research reported in this publication was supported in part by the National Institute on Aging of the National Institutes of Health under Award Number P30AG024409. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. SPECIAL FEATURE: INTRODUCTION Antimicrobial resistance and the role of vaccines SPECIAL FEATURE: INTRODUCTION David E. Blooma, Steven Blackb, David Salisburyc, and Rino Rappuolid,e,1 Stanley Falkow (Fig. 1) dedicated his life’s work to being reported (6). These health consequences will the study of bacteria and infectious disease. He have damaging social and economic sequelae, such was a leader in the discovery of the mechanisms as lost productivity due to increased morbidity and of antibiotic resistance and among the first to mortality, and even social distancing, as fear of inter- recognize and raise the alarm about the problem of multidrug resistance. The articles of this Spe- personal contact grows. ’ cial Feature on Antimicrobial Resistance and the Although projections of AMR s future burden Role of Vaccines are dedicated to his memory depend on several assumptions and are therefore (Box 1). uncertain, the idea that the health and economic consequences of AMR will become significant is rea- Rising antimicrobial resistance (AMR) is one of the sonable. In 2014, the Review on Antimicrobial Resis- greatest health challenges the world currently faces.
    [Show full text]
  • Microbiology Immunology Cent
    years This booklet was created by Ashley T. Haase, MD, Regents Professor and Head of the Department of Microbiology and Immunology, with invaluable input from current and former faculty, students, and staff. Acknowledgements to Colleen O’Neill, Department Administrator, for editorial and research assistance; the ASM Center for the History of Microbiology and Erik Moore, University Archivist, for historical documents and photos; and Ryan Kueser and the Medical School Office of Communications & Marketing, for design and production assistance. UMN Microbiology & Immunology 2019 Centennial Introduction CELEBRATING A CENTURY OF MICROBIOLOGY & IMMUNOLOGY This brief history captures the last half century from the last history and features foundational ideas and individuals who played prominent roles through their scientific contributions and leadership in microbiology and immunology at the University of Minnesota since the founding of the University in 1851. 1. UMN Microbiology & Immunology 2019 Centennial Microbiology at Minnesota MICROBIOLOGY AT MINNESOTA Microbiology at Minnesota has been From the beginning, faculty have studied distinguished from the beginning by the bacteria, viruses, and fungi relevant to breadth of the microorganisms studied important infectious diseases, from and by the disciplines and sub-disciplines early studies of diphtheria and rabies, represented in the research and teaching of through poliomyelitis, streptococcal and the faculty. The Microbiology Department staphylococcal infection to the present itself, as an integral part of the Medical day, HIV/AIDS and co-morbidities, TB and School since the department’s inception cryptococcal infections, and influenza. in 1918-1919, has been distinguished Beyond medical microbiology, veterinary too by its breadth, serving historically microbiology, microbial physiology, as the organizational center for all industrial microbiology, environmental microbiological teaching and research microbiology and ecology, microbial for the whole University.
    [Show full text]
  • The NIH Human Microbiome Project Authors: the NIH HMP Working Group (
    Downloaded from genome.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press The NIH Human Microbiome Project Authors: the NIH HMP Working Group (http://nihroadmap.nih.gov/hmp/members.asp) ABSTRACT: The Human Microbiome Project ( HMP), funded as an initiative of the NIH Roadmap for Biomedical Research (http://nihroadmap.nih.gov), is a multi-component community resource. The goals of the HMP are (1) to take advantage of new, high-throughput technologies to characterize the human microbiome more fully by studying samples from multiple body sites from each of at least 250 “normal” volunteers; (2) to determine whether there are associations between changes in the microbiome and health/disease by studying several different medical conditions; and (3) to provide both a standardized data resource and new technological approaches to enable such studies to be undertaken broadly in the scientific community. The ethical, legal, and social implications of such research are being systematically studied as well. The ultimate objective of the HMP is to demonstrate that there are opportunities to improve human health through monitoring or manipulation of the human microbiome. The history and implementation of this new program are described here. INTRODUCTION: It has been known for some time that the human body is inhabited by at least ten times more bacteria than the number of human cells in the body, and that the majority of those bacteria are found in the human gastrointestinal tract (Savage 1977). Throughout the history of microbiology, most human studies have focused on the disease-causing organisms found on or in people; fewer studies have examined the benefits of the resident bacteria.
    [Show full text]
  • Affiliates Letter the Official Newsletter for FEMS Affiliates
    ALSO IN THIS ISSUE PUBLICATIONS / GRANTS CORNER / FEMS MEMBERS / OPPORTUNITIES / DEADLINES AFFILIATES LETTER THE OFFICIAL NEWSLETTER FOR FEMS AFFILIATES Meet FEMS Delegate Don’t miss Anastasiya Sidarenka an update Dr. Anastasiya Sidarenka It seems miles away, but soon the is FEMS Delegate of the countdown for FEMS 2019 will will Belarussian Non-governmental begin. Don’t want to miss an update Association of Microbiologists. on everything the Congress has to As an experienced researcher offer? Then sign up now for the FEMS in the area of microbial Congress newsletter. physiology and genetics, she is the principle investigator on the projects aimed at molecular detection of plant pathogenic bacteria and fungi and application of microorganisms for plant protection from diseases. Her research interests also in- clude the study of human gut microbiota and microbiota of extreme Antarctic ecosystems. In 2017, the first time after a long stalemate period in the history of Be- larusian Microbiological Society (BNAM) organized the Congress of Mi- crobiologists of Belarus. This marker event rallied microbiologists from different parts of the country to discuss the current state and identify key trends for the development of microbiological science in Belarus, share successes and challenges facing members in their research work, consolidate the efforts for solving important public problems. BNAM has been a full Member of FEMS since 2010 and is currently led by a group of dedicated Belarussian scientists. We asked Dr Anastasiya Sidarenka what it means
    [Show full text]
  • Biographical Notes on Scientists Involved in the Asilomar Process M.J
    International Dimensions of Ethics Education in Science and Engineering Case Study Series: Asilomar Conference on Laboratory Precautions Appendix D: Biographical Notes on Scientists involved in the Asilomar Process M.J. Peterson Version 1, June 2010 Edward A. Adelberg (1920-2009). PhD Yale 1949. Chair of Yale Department of Microbiology 1961-64 and 1970-72; a founding member of Yale Department of Genetics. Deputy Provost for the Biomedical Sciences, 1983-91. Specialist in plasmid biochemistry of E. coli. Ephraim Anderson (1911-2006). M.D., Durham University. Served in the Royal Army Medical Corps during World War II where he developed interests in Epidemiology. Researcher in Enteric Laboratory of the British Public Health Laboratory Service 1947, Deputy Director 1952, Director 1954-1978. Came to public notice for tracing sources of typhoid outbreaks in Zermatt (1963) and Aberdeen (1964). Built on earlier work by Japanese researchers to demonstrate the plasmid-based pathways by which bacteria could spread antibiotic resistance to others and became the world’s leading expert on antibiotic resistance. Also prominent in efforts to limit use of antibiotics in raising animals. Fellow of the Royal Society 1968; Companion of the Order of the British Empire 1976. Eric Ashby, Baron Ashby (1904-1992). Lecturer in Botany, Imperial College London 1931-35; Reader in Botany Bristol University 1935-37; Professor of Botany University of Sydney 1938-1946; Chair of Botany, University of Manchester 1947-50. Turned to administration as President and Vice-Chancellor of Queen's University, Belfast 1950-59; Master of Clare College in Cambridge University 1959-67 and Vice-Chancellor of Cambridge University 1967-1969.
    [Show full text]
  • Nature Medicine Essay
    LASKER~KOSHLAND SPECIAL ACHIEVEMENT IN MEDICAL SCIENCE AWARD COMMENTARY I never met a microbe I didn’t like Stanley Falkow At the age of 11, I read Paul de Kruif’s Microbe Hunters, which dramatized the discovery of bacteria and viruses and their roles in human disease. The heroes of Microbe Hunters—Louis Pasteur, Robert Koch and others—became my heroes, and I dreamed of becoming a bacte- riologist, doing research on the bacteria that cause disease. I was lucky enough to fulfill my boyhood dream; however, I could never have imagined the path I eventually followed, or how much my views of microbes and disease would change (and continue to do so) in the process. Of course, I did not make this journey alone. During the five decades I worked as an active scientist, I helped train over 100 graduate Figure 1 Lab alumni reunion in 2004, Falkow/Tompkins home, Hamilton, Montana, USA. Photo students, postdoctoral fellows and clinical fel- courtesy of Manuel Amieva. lows, and collaborated with 75 other scientists (Fig. 1). Each of us, in our own way, wondered, Professor Herman Chase, a mouse geneticist, nicity. I was unable to transfer any gene from “What is a pathogen?” thought about my question and announced Salmonella or Shigella that altered the measur- that he had just the book to start me on my able pathogenicity or host range of another Entering the genetic and molecular world voyage, the just-published compilation The Salmonella species, or that made E. coli K-12 I was a hospital bacteriologist and an autopsy Chemical Basis of Heredity1.
    [Show full text]
  • The Ways of Microbes
    In the Company of Microbes Ten Years of Small Things Considered Elio Schaechter Artwork by Judith Schaechter In the Company of Microbes Ten Years of Small Things Considered Washington, DC Copyright © 2016 American Society for Microbiology. All rights reserved. No part of this publication may be reproduced or transmitted in whole or in part or reused in any form or by any means, electronic or mechanical, including photocopying and recording, or by any information storage and retrieval system, without permission in writing from the publisher. Disclaimer: To the best of the publisher’s knowledge, this publication provides information concerning the subject matter covered that is accurate as of the date of publication. The publisher is not providing legal, medical, or other professional services. Any reference herein to any specific commercial products, procedures, or services by trade name, trademark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favored status by the American Soci- ety for Microbiology (ASM). The views and opinions of the author(s) expressed in this publication do not necessarily state or reflect those of ASM, and they shall not be used to advertise or endorse any product. Library of Congress Cataloging-in-Publication Data Names: Schaechter, Moselio, editor. | Schaechter, Judith, 1961- illustrator. Title: In the company of microbes : ten years of Small Things Considered / edited by Elio Schaechter ; artwork by Judith Schaechter. Description: Washington, DC : ASM Press, [2016] | ?2016 | Includes bibliographical references. Identifiers: LCCN 2016011177 | ISBN 9781555819590 (pbk.) Subjects: LCSH: Microbiology–Blogs. | Microorganisms–Blogs. Classification: LCC QR56 .I5 2016 | DDC 576--dc23 LC record available at http://lccn.loc.gov/2016011177 10 9 8 7 6 5 4 3 2 1 All Rights Reserved Printed in the United States of America Address editorial correspondence to ASM Press, 1752 N St., N.W., Washington, DC 20036-2904, USA Send orders to ASM Press, P.O.
    [Show full text]
  • Lasker Interactive Research Nom'18.Indd
    THE 2018 LASKER MEDICAL RESEARCH AWARDS Nomination Packet albert and mary lasker foundation November 1, 2017 Greetings: On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination for the 2018 Lasker Medical Research Awards. Since 1945, the Lasker Awards have recognized the contributions of scientists, physicians, and public citizens who have made major advances in the understanding, diagnosis, treatment, cure, and prevention of disease. The Medical Research Awards will be offered in three categories in 2018: Basic Research, Clinical Research, and Special Achievement. The Lasker Foundation seeks nominations of outstanding scientists; nominations of women and minorities are encouraged. Nominations that have been made in previous years are not automatically reconsidered. Please see the Nomination Requirements section of this booklet for instructions on updating and resubmitting a nomination. The Foundation accepts electronic submissions. For information on submitting an electronic nomination, please visit www.laskerfoundation.org. Lasker Awards often presage future recognition of the Nobel committee, and they have become known popularly as “America’s Nobels.” Eighty-seven Lasker laureates have received the Nobel Prize, including 40 in the last three decades. Additional information on the Awards Program and on Lasker laureates can be found on our website, www.laskerfoundation.org. A distinguished panel of jurors will select the scientists to be honored with Lasker Medical Research Awards. The 2018 Awards will
    [Show full text]
  • 158273436.Pdf
    4. , .;z.. ", ,:,. - 21sk , 44 "00,4 'WM 4 44 44 4 COLD SPRING HARBOR LABORATORY OF QUANTITATIVE BIOLOGY ESTABLISHED JULY 1, 1963 ANNUAL REPORT 1967 COLD SPRING HARBOR, LONG ISLAND, NEW YORK COLD SPRING HARBOR LABORATORY OF QUANTITATIVE BIOLOGY COLD SPRING HARBOR, LONG ISLAND,NEW YORK OFFICERS OF THE CORPORATION Chairman: Dr. H. Bentley Glass Secretary: Dr. Harry G. Albaum 1st Vice-Chairman: Mr. Walter H. Page Treasurer: Mr. Richard B. McAdoo 2nd Vice-Chairman: Assistant Secretary-Treasurer Dr. James D. Watson Mr. John B. Philips Laboratory Director: Dr. John Cairns BOARD OF TRUSTEES AND PARTICIPATING INSTITUTIONS Rockefeller University Albert Einstein College of Medicine Dr. Norton Zinder Dr. Harry Eagle Long Island Biological Association Duke University Mr. Walter H. Page Dr. Samson Gross Princeton University Brooklyn College of the City University of Dr. Arthur B. Pardee New York Dr. Harry G. Albaum New York University Medical Center The Public Health Research Institute of New York University of the City of New York, Inc. Dr. Alan W. Bernheimer Dr. Paul Margolin Sloan-Kettering Institute for Cancer Research Dr. Leo Wade INDIVIDUAL TRUSTEES Dr. H. Bentley Glass Mr. Richard B. McAdoo Dr. I. C. Gunsalus Dr. Lewis Sarett Dr. Alexander Hollaender Mr. Dudley W. Stoddard Dr. James D. Watson TABLE OF CONTENTS Board of Trustees 2 Director's Report 5-7 Year-round Research Activities 8-15 32nd Cold Spring Harbor Symposium "Antibodies" 16-17 Phycomyces Workshop 18-19 Summer Post-Graduate Training Courses 20-22 Undergraduate Research Participation
    [Show full text]
  • The Prokaryotes Third Edition the Prokaryotes a Handbook on the Biology of Bacteria
    The Prokaryotes Third Edition The Prokaryotes A Handbook on the Biology of Bacteria Third Edition Volume 1: Symbiotic Associations, Biotechnology, Applied Microbiology Martin Dworkin (Editor-in-Chief), Stanley Falkow, Eugene Rosenberg, Karl-Heinz Schleifer, Erko Stackebrandt (Editors) Editor-in-Chief Professor Dr. Martin Dworkin Department of Microbiology University of Minnesota Box 196 University of Minnesota Minneapolis, MN 55455-0312 USA Editors Professor Dr. Stanley Falkow Professor Dr. Karl-Heinz Schleifer Department of Microbiology Department of Microbiology and Immunology Technical University Munich Stanford University Medical School 80290 Munich 299 Campus Drive, Fairchild D039 Germany Stanford, CA 94305-5124 USA Professor Dr. Erko Stackebrandt DSMZ- German Collection of Microorganisms Professor Dr. Eugene Rosenberg and Cell Cultures GmbH Department of Molecular Microbiology Mascheroder Weg 1b and Biotechnology 38124 Braunschweig Tel Aviv University Germany Ramat-Aviv 69978 Israel Library of Congress Control Number: 2005928710 ISBN-10: 0-387-25476-5 e-ISBN 0-387-•••••-• Printed on acid-free paper. ISBN-13: 978-0387-25476-0 © 2006 Springer Science+Business Media, Inc. All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, Inc., 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights.
    [Show full text]
  • Infection and Immunity Volume 43 * January 1984 Number 1 J
    INFECTION AND IMMUNITY VOLUME 43 * JANUARY 1984 NUMBER 1 J. W. Shands, Jr., Editor in Chief (1984) University of Florida, Gainesville Phillip J. Baker, Editor (1985) Stephan E. Mergenhagen, Editor (1984) National Institute ofAllergy and Peter F. Bonventre, Editor (1984) National Institute ofDental Research Infectious Diseases University of Cincinnati Bethesda, Md. Bethesda, Md. Cincinnati, Ohio John H. Schwab, Editor (1985) Edwin H. Beachey, Editor (1988) Arthur G. Johnson, Editor (1986) University of North Carolina, VA Medical Center University ofMinnesota, Duluth Medical School Memphis, Tenn. Chapel Hill EDITORIAL BOARD Leonard C. Altman (1986) John C. Feeley (1985) Julius P. Kreier (1986) Stephen W. Russell (1985) Michael A. Apicella (1985) Robert Finberg (1984) Maurice J. Lefford (1984) Catherine Saelinger (1984) Roland Arnold (1984) John R. Finerty (1984) Thomas Lehner (1986) Edward J. St. Martin (1985) Joel B. Baseman (1985) Robert Fitzgerald (1986) Stephan H. Leppla (1985) Irvin E. Salit (1986) Elmer L. Becker (1984) Samuel B. Formal (1986) Michael Loos (1984) Anthony J. Sbarra (1984) Neil Blacklow (1984) John Gallin (1985) John Mansfield (1985) Charles F. Schachtele (1985) Arnold S. Bleiweis (1984) Peter Gemski (1985) Zell A. McGee (1985) Julius Schachter (1986) William H. Bowen (1985) Robert Genco (1985) Jerry R. McGhee (1985) Jerome L. Schulman (1985) Robert R. Brubaker (1986) Ronald J. Gibbons (1985) Douglas D. McGregor (1985) Alan Sher (1984) Ward Bullock, Jr. (1985) Frances Gillin (1984) Floyd C. McIntire (1985) Gerald D. Shockman (1986) Charles Carpenter (1985) Mayer B. Goren (1985) Monte Meltzer (1986) Phillip Smith (1985) Bruce Chassy (1984) Harry Greenberg (1985) Jiri Mestecky (1986) Ralph Snyderman (1985) John 0.
    [Show full text]